Next, to test the efficiency of ROP antigen presentation to CD8+ T cells, we used PBMCs from HIV and TB co-infected patients with depleted CD4+ lymphocyte levels and examined their ability to respond to TB antigens. This evidence concerns the gene CD8A and tuberculosis.